Health Care

Explore how Zoetis’s strategic focus on biotech, pricing power, and AI-driven diagnostics keeps it a top animal‑health firm and a resilient, income‑generating investment amid market volatility.

Vertex Pharmaceuticals’ shares hit a new 52‑week high, buoyed by breakthrough CF, gene‑editing, and KRAS trial data that boost investor confidence.

Quest Diagnostics’ phantom‑stock deal reveals how executive incentives tie to shareholder value and highlights the company’s AI and automation plans to boost margins and speed in a fast‑growing diagnostics market.

Explore how Sartorius Stedim Biotech’s growing liquidity reserve and cell‑therapy focus boost market stability and M&A appeal, positioning it for biotech growth.

Medtronic PLC’s shares surge as investors shift toward defensive healthcare stocks, highlighting the company’s solid growth and the market’s pivot away from tech overvaluation.

Intuitive Surgical’s July 2 gain highlights robotic‑surgery’s proven safety, faster recoveries, and cost savings—fueling investor confidence and clinical adoption.

Argenx’s FcRn‑targeted biologic Vyvgart offers a precision approach to autoimmune disease, spotlighting its market potential, regulatory hurdles, and competitive edge.

Haleon PLC deepens its Azure partnership, deploying Microsoft Copilot across 5 years to boost AI‑driven drug research, regulatory compliance, and global productivity.

Illumina’s directors swapped cash retainers for equity, boosting long‑term alignment and investor confidence while the company’s NGS tech drives oncology, pharmacogenomics and pathogen surveillance.

Discover why the Galien Foundation is moving its award to Guangzhou—explore China’s booming biotech scene, regulatory shifts, and AI‑driven opportunities.